Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method

Cancer

Volumn 97, Issue 7, 2003, Pages 1672-1680

  An, Hee Jung ^a   Cho, Nam Hoon ^b   Lee, Sun Young ^a   Kim, In Ho ^a   Lee, Chan ^a   Kim, Seung Jo ^a   Mun, Mi Sook ^a   Kim, Se Hyun ^a   Jeong, Jeongmi Kim ^c  

^a CHA University   (South Korea)

^b Yonsei University   (South Korea)

^c Biomedlab Co   (South Korea)

Author keywords

Cervical carcinoma; DNA chip; Human papillomavirus (HPV); Squamous intraepithelial lesion

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER CYTODIAGNOSIS; CANCER RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DNA MICROARRAY; DNA PROBE; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMA VIRUS 52; HUMAN PAPILLOMA VIRUS 56; HUMAN PAPILLOMA VIRUS 58; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMA VIRUS; PRECANCER; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SQUAMOUS EPITHELIUM; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADULT; CARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0037377582     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11235     Document Type: Article

References (27)

1. Parkin DM, Muir CS, Whelan SL, et al. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ. 1992;120:45-173.
2. Devilliers EM. Heterogeneity of the human papillomavirus group. J Virol. 1989;63:4898-4903.
3. Munoz N, Bosch FX. Current views on the epidemiology of HPV and cervical cancer. In: Lacey C, editor. Papillomavirus reviews: current research on papillomavirus. London: Leeds University Press, 1996:227-237.
4. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer. A worldwide perspective. J Natl Cancer Inst. 1995;87:796-802.
5. Brown DR, McClowry TL, Woods K, Fife KH. Nucleotide sequence and characterization of human papillomavirus type 83, a novel genital papillomavirus. Virology. 1999;260:165-172.
6. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000;92:464-474.
7. Cox JT, Lorincz AT, Schiffman MH, et al. Human papillomavirus testing by hybrid capture appears to be useful in tri-aging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995;172:946-954.
8. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet. 1995;345:1533-1537.
9. Nobbenhuis M, Meijer CJLM, van den Brule AJC, et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer. 2001;84:796-801.
10. Bosch FX, Munoz N, De Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer. 1992;52:750-758.
11. Becker TM, Wheeler CM, McGough NS, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among Southwestern Hispanic and non-Hispanic white women. JAMA. 1994;271:1181-1188.
12. Wright TC, Kurman RJ. A critical review of the morphologic classification systems of preinvasive lesions of the cervix. The scientific basis for the paradigm. In: Lacey C, editor. Papillomavirus reviews: current research on papillomavirus. London: Leeds University Press, 1994:215-225.
13. Lungu O, Sun XW, Felix J, et al. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA. 1992;267:2493-2496.
14. Kalantari M, Karlsen F, Johansson B, et al. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: a study on 476 Stockholm women, using PCR for detection and typing of HPV. Hum Pathol. 1997;28:899-904.
15. Takahashi Y, Yamade I, Nakamura T, et al. Infection by human papillomavirus types 6, 11, 16, 18, 31, 33 and 35 of the cervix in Japanese women. Int J Gynecol Cancer. 1995;5:45-48.
16. Genest DR, Stein L, Cibas E, et al. A binary (Bethesda) system for classifying cervical cancer precursors: criteria, reproducibility, and viral correlates. Hum Pathol. 1993;24:730-736.
17. Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol. 2001;64:550-559.
18. Lorincz AT, Temple GF, Kurman J, et al. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst. 1987;79:671-677.
19. Bergeron CA, Ferenczy A, Sah KV, Naghashfar Z. Multicentric human papillomavirus infections of the female genital tract: correlation of viral types with abnormal mitotic figures, colposcopic presentation, and location. Obstet Gynecol. 1987;69:736-742.
20. Crum CP, Mitao M, Levine RU, Silverstein SJ. Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol. 1985;54:657-681.
21. Reid RM, Greenberg AB, Jenson M, et al. Sexually transmitted papillomaviral infections. I: the anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol. 1987;156:212-222.
22. Schneider A, Kraus H, Schuhmann R, Gissmann L. Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer. 1985;35:443-448.
23. ALTS Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst. 2000;92:397.
24. Travers H. Quality assurance indicators in anatomic pathology. Arch Pathol Lab Med. 1990;114:1149-1156.
25. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
26. Schneider A, Hoyer H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer. 2000;20;89:529-534.
27. Petry KU, Bohmer G, Iftner T, Flemming P, Stoll M, Schmidt RE. Human papillomavirus testing in primary screening for cervical cancer of human immunodeficiency virus-infected women, 1990-1998. Gynecol Oncol. 1999;75:427-431.